ENHERTU® Approved in the U.S. as the First HER2 Directed Therapy for Patients with HER2 Low Metastatic Breast Cancer
Based on DESTINY-Breast04 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU reduced risk of disease progression or death by 50%...

Xiaomi starts global HyperOS 4 rollout with Android 17; POCO F8 Pro in first wave
Chase wins toss, West Indies 69/3 on day one as WI look to seal series vs Bangladesh in Sylhet
PFC declares ₹4.10 second interim dividend as standalone Q2 PAT rises 11.76%
West Indies Capitalise on Dhaka Dominance as Bangladesh Fight for Survival in Sylhet
Brown’s late block lifts 76ers past Pistons as LeBron makes 16,000 mark 





























